Evidence map›Paper›PMID 38290825›Full record

ArticleJournal of medical genetics2024

Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals.

Lottie D Morison, Milou G P Kennis, Dmitrijs Rots, Arianne Bouman, Joost Kummeling, Elizabeth Palmer, Adam P Vogel, Frederique Liegeois, Amanda Brignell, Siddharth Srivastava and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of medical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Childhood motor speech disorders: who to prioritise for genetic testing.European journal of human genetics : EJHG · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Lottie D MorisonSpeech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia.ORCID 0000-0003-2822-6522
Milou G P KennisDepartment of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.
Dmitrijs RotsDepartment of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.
Arianne BoumanDepartment of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.
Joost KummelingDepartment of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.
Elizabeth PalmerSydney Children's Hospital Network, Randwick, New South Wales, Australia.
Adam P VogelDepartment of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-3505-2631
Frederique LiegeoisGreat Ormond Street Institute of Child Health, University College London, London, UK.
Amanda BrignellDepartment of Paediatrics, Monash University, Clayton, Victoria, Australia.
Siddharth SrivastavaDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-7008-1879
Zoe FrazierDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
Di MilnesGenetic Health Queensland, Herston, Queensland, Australia.
Himanshu GoelHunter Genetics, Waratah, New South Wales, Australia.
David J AmorSpeech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Ingrid E SchefferMelbourne Brain Centre, Austin Health, Heidelberg, Victoria, Australia.
Tjitske KleefstraDepartment of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.
Angela T MorganSpeech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia angela.morgan@mcri.edu.au.ORCID 0000-0003-1147-7405

Funding

Investigating the Genetic Landscape of Cerebral PalsyK23NS119666 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI SRIVASTAVA, SIDDHARTH · 2021 to 2025
$1.1M
NINDS NIH HHS K23 NS119666
6 · The paper itself

Abstract

objectivesSpeech and language impairments are core features of the neurodevelopmental genetic condition Kleefstra syndrome. Communication has not been systematically examined to guide intervention recommendations. We define the speech, language and cognitive phenotypic spectrum in a large cohort of individuals with Kleefstra syndrome.

method103 individuals with Kleefstra syndrome (40 males, median age 9.5 years, range 1-43 years) with pathogenic variants (52 9q34.3 deletions, 50 intragenic variants, 1 balanced translocation) were included. Speech, language and non-verbal communication were assessed. Cognitive, health and neurodevelopmental data were obtained.

resultsThe cognitive spectrum ranged from average intelligence (12/79, 15%) to severe intellectual disability (12/79, 15%). Language ability also ranged from average intelligence (10/90, 11%) to severe intellectual disability (53/90, 59%). Speech disorders occurred in 48/49 (98%) verbal individuals and even occurred alongside average language and cognition. Developmental regression occurred in 11/80 (14%) individuals across motor, language and psychosocial domains. Communication aids, such as sign and speech-generating devices, were crucial for 61/103 (59%) individuals including those who were minimally verbal, had a speech disorder or following regression.

conclusionsThe speech, language and cognitive profile of Kleefstra syndrome is broad, ranging from severe impairment to average ability. Genotype and age do not explain the phenotypic variability. Early access to communication aids may improve communication and quality of life.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 9CognitionCraniofacial AbnormalitiesIntellectual DisabilityPhenotypeAdolescentAdultChildChild, PreschoolFemaleHeart Defects, CongenitalHumansInfantIntelligenceLanguageGenetics, BehavioralHuman GeneticsNeurologyPediatricsPhenotype

Identifiers

PMID38290825
PMCPMC11148766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.